As Europe re-evaluates its pharmaceutical policy framework the challenge for the next decade(s) is not if medical innovation will happen, but where it will happen.
Five EFPIA Board members tell us why it matters to patients, to health systems, to our research ecosystem and to our economy. Read more here....
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.